Beijing Scitop (China) Performance
| 300858 Stock | 16.47 0.25 1.54% |
On a scale of 0 to 100, Beijing Scitop holds a performance score of 7. The firm shows a Beta (market volatility) of 0.0541, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Beijing Scitop's returns are expected to increase less than the market. However, during the bear market, the loss of holding Beijing Scitop is expected to be smaller as well. Please check Beijing Scitop's downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether Beijing Scitop's price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Beijing Scitop Bio are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Beijing Scitop sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0091 | Payout Ratio 0.533 | Last Split Factor 1.5:1 | Forward Dividend Rate 0.15 | Ex Dividend Date 2024-07-03 |
1 | Beijing Scitop Bio-tech Co., Ltd.s Earnings Havent Escaped The Attention Of Investors - Simply Wall St | 09/27/2024 |
| Begin Period Cash Flow | 875.3 M | |
| Free Cash Flow | -71.2 M |
Beijing |
Beijing Scitop Relative Risk vs. Return Landscape
If you would invest 1,403 in Beijing Scitop Bio on September 1, 2024 and sell it today you would earn a total of 244.00 from holding Beijing Scitop Bio or generate 17.39% return on investment over 90 days. Beijing Scitop Bio is generating 0.3273% of daily returns and assumes 3.3461% volatility on return distribution over the 90 days horizon. Simply put, 29% of stocks are less volatile than Beijing, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Beijing Scitop Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Beijing Scitop's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Beijing Scitop Bio, and traders can use it to determine the average amount a Beijing Scitop's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0978
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 300858 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.35 actual daily | 29 71% of assets are more volatile |
Expected Return
| 0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Beijing Scitop is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beijing Scitop by adding it to a well-diversified portfolio.
Beijing Scitop Fundamentals Growth
Beijing Stock prices reflect investors' perceptions of the future prospects and financial health of Beijing Scitop, and Beijing Scitop fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Beijing Stock performance.
| Return On Equity | 0.0533 | ||||
| Return On Asset | 0.0195 | ||||
| Profit Margin | 0.31 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 3.95 B | ||||
| Shares Outstanding | 263.5 M | ||||
| Price To Book | 2.46 X | ||||
| Price To Sales | 14.42 X | ||||
| Revenue | 299.24 M | ||||
| Gross Profit | 191.88 M | ||||
| EBITDA | 76.02 M | ||||
| Net Income | 93.48 M | ||||
| Total Debt | 77.1 M | ||||
| Book Value Per Share | 6.70 X | ||||
| Cash Flow From Operations | 107.27 M | ||||
| Earnings Per Share | 0.35 X | ||||
| Total Asset | 1.81 B | ||||
| Retained Earnings | 323.85 M | ||||
About Beijing Scitop Performance
By analyzing Beijing Scitop's fundamental ratios, stakeholders can gain valuable insights into Beijing Scitop's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Beijing Scitop has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Beijing Scitop has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Beijing Scitop is entity of China. It is traded as Stock on SHE exchange.Things to note about Beijing Scitop Bio performance evaluation
Checking the ongoing alerts about Beijing Scitop for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Beijing Scitop Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Beijing Scitop Bio had very high historical volatility over the last 90 days | |
| Beijing Scitop Bio is unlikely to experience financial distress in the next 2 years | |
| About 55.0% of the company shares are owned by insiders or employees |
- Analyzing Beijing Scitop's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Beijing Scitop's stock is overvalued or undervalued compared to its peers.
- Examining Beijing Scitop's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Beijing Scitop's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Beijing Scitop's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Beijing Scitop's stock. These opinions can provide insight into Beijing Scitop's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Beijing Stock analysis
When running Beijing Scitop's price analysis, check to measure Beijing Scitop's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beijing Scitop is operating at the current time. Most of Beijing Scitop's value examination focuses on studying past and present price action to predict the probability of Beijing Scitop's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beijing Scitop's price. Additionally, you may evaluate how the addition of Beijing Scitop to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |